What is TFR2 (Transferrin Receptor 2) related type 3 hereditary hemochromatosis and what are its symptoms, specifically arthralgia (joint pain)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TFR2-Related Type 3 Hereditary Hemochromatosis and Arthralgia

TFR2-related type 3 hereditary hemochromatosis is a rare form of iron overload disorder characterized by mutations in the transferrin receptor 2 gene, with arthralgia (joint pain) being a prominent early symptom that typically affects the metacarpophalangeal joints and ankles, and does not respond to phlebotomy treatment. 1, 2

What is TFR2-Related Type 3 Hereditary Hemochromatosis?

TFR2-related hemochromatosis (also known as Type 3 HH) is one of the non-HFE forms of hereditary hemochromatosis. It is characterized by:

  • Genetic mutations in the transferrin receptor 2 (TFR2) gene
  • Abnormal iron metabolism leading to excessive iron deposition in organs
  • Typically presents at a younger age than the more common HFE-related (Type 1) hemochromatosis
  • Rare occurrence compared to HFE-related hemochromatosis

Pathophysiology

The underlying mechanism of TFR2-related hemochromatosis involves:

  • Dysfunction of the transferrin receptor 2 protein, which plays a key role in iron sensing
  • Decreased expression of hepcidin, the principal iron-regulatory hormone
  • Abnormal regulation of the hepcidin-ferroportin axis
  • Increased intestinal iron absorption and iron release from macrophages
  • Progressive iron accumulation in parenchymal organs (liver, heart, pancreas, joints) 1, 3

Clinical Presentation and Symptoms

Patients with TFR2-related hemochromatosis typically present with:

  • Arthralgia (joint pain) - often the earliest and most prominent symptom
  • Elevated serum ferritin levels and transferrin saturation
  • Low hepcidin/ferritin ratio
  • Presentation typically in young adulthood (ages 25-41) 2

Other clinical manifestations may include:

  • Abnormal liver function
  • Liver fibrosis or cirrhosis
  • Diabetes
  • Hypogonadism
  • Cardiomyopathy
  • Skin pigmentation 4

What is Arthralgia in TFR2-Related Hemochromatosis?

Arthralgia refers to joint pain and is a common and significant symptom in hereditary hemochromatosis, particularly in TFR2-related type:

Characteristics of hemochromatosis-related arthralgia:

  • Typically affects the 2nd and 3rd metacarpophalangeal joints (hands)
  • Also commonly affects ankles (69.3%), hips (56.8%), and wrists (46.9%) 1
  • Occurs at a younger age compared to typical osteoarthritis
  • Features rapid progression to cartilage loss
  • Characterized by exuberant osteophytes (bone spurs)
  • Often includes chondrocalcinosis (calcium crystal deposits in joint cartilage) in about 50% of cases 1

Radiographic findings:

  • Degenerative changes
  • Joint space narrowing
  • Osteophytes
  • Subchondral cysts
  • Chondrocalcinosis in approximately half of cases 1

Important clinical consideration:

Arthralgia in TFR2-related hemochromatosis does not typically respond to phlebotomy therapy and can develop or persist even while on maintenance therapy. This is a critical distinction from some other symptoms of iron overload that may improve with iron reduction. 1

Diagnosis

The diagnosis of TFR2-related hemochromatosis should be considered in:

  • Young adults presenting with unexplained arthralgia
  • Elevated transferrin saturation (TSAT) and ferritin levels
  • Absence of HFE gene mutations (C282Y, H63D)
  • Low hepcidin/ferritin ratio
  • Liver iron content >100 μmol/g 2

Diagnostic workup includes:

  • Serum iron studies (ferritin, transferrin saturation)
  • Genetic testing for TFR2 mutations
  • Assessment of liver iron content (MRI or biopsy)
  • Evaluation for other organ involvement 1, 2

Treatment

Management of TFR2-related hemochromatosis includes:

  • Phlebotomy (therapeutic blood removal) to reduce iron overload
  • Monitoring of serum ferritin and transferrin saturation
  • Screening for complications (liver disease, diabetes, cardiac involvement)

For arthralgia specifically:

  • Analgesics and non-steroidal anti-inflammatory drugs
  • Physiotherapy
  • Joint replacement surgery in severe cases 1

Clinical Importance

Early diagnosis of TFR2-related hemochromatosis is crucial to:

  • Prevent progressive liver damage and other organ complications
  • Initiate appropriate treatment for arthralgia
  • Screen family members for the condition
  • Provide genetic counseling 2

Despite the rarity of TFR2-related hemochromatosis, awareness among physicians is important for early diagnosis and prevention of complications, particularly since arthralgia may be the earliest presenting symptom in young adults.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.